[Revival of oral strophanthin therapy]. 1951

R ASCHENBRENNER, and K FOTH

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001688 Biological Products Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay. Biologic,Biologic Drug,Biologic Product,Biological,Biological Drug,Biological Medicine,Biological Product,Biologics,Biopharmaceutical,Natural Product,Natural Products,Biologic Drugs,Biologic Medicines,Biologic Pharmaceuticals,Biologic Products,Biological Drugs,Biological Medicines,Biologicals,Biopharmaceuticals,Products, Biological,Drug, Biologic,Drug, Biological,Drugs, Biologic,Drugs, Biological,Medicine, Biological,Medicines, Biologic,Medicines, Biological,Pharmaceuticals, Biologic,Product, Biologic,Product, Biological,Product, Natural
D013328 Strophanthins A number of different cardioactive glycosides obtained from Strophanthus species. OUABAIN is from S. gratus and CYMARINE from S. kombe. They are used like the digitalis glycosides. Strophanthin

Related Publications

R ASCHENBRENNER, and K FOTH
February 1959, Prensa medica argentina,
R ASCHENBRENNER, and K FOTH
April 1952, Medizinische Klinik,
R ASCHENBRENNER, and K FOTH
June 1978, ZFA. Zeitschrift fur Allgemeinmedizin,
R ASCHENBRENNER, and K FOTH
June 1968, Die Medizinische Welt,
R ASCHENBRENNER, and K FOTH
July 1969, Die Medizinische Welt,
R ASCHENBRENNER, and K FOTH
July 1953, Deutsches medizinisches Journal,
R ASCHENBRENNER, and K FOTH
July 1969, Die Medizinische Welt,
R ASCHENBRENNER, and K FOTH
January 1952, Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie,
R ASCHENBRENNER, and K FOTH
September 1953, Arztliche Wochenschrift,
R ASCHENBRENNER, and K FOTH
March 1975, MMW, Munchener medizinische Wochenschrift,
Copied contents to your clipboard!